Award
Delivery Order #SPE2DR26FNV8E
Delivery Order for Alfuzosin HCL ER Tablets under Pharmaceutical Supply Contract
Buyer
Defense Logistics Agency
Award Amount
$4,856.81
Ceiling
$4,856.81
Awarded
March 09, 2026
Period of Performance
Mar 09, 2026 – Mar 10, 2026
Identifier
SPE2DR26FNV8E
NAICS
424210
This award is a delivery order contract issued under an existing indefinite delivery vehicle held by AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order procures Alfuzosin HCL ER 10 mg tablets, highlighting the agency's ongoing requirements for critical pharmaceutical products. AmerisourceBergen, known for its extensive pharmaceutical distribution network, provides essential medications supporting public health needs. The delivery order specifically covers a short-term supply of these tablets, reflecting targeted procurement to meet immediate healthcare demands. The contract was awarded within the framework of a broader multi-year agreement ensuring continuous pharmaceutical supply. While this delivery order is not subject to competitive bidding as it stems from the parent indefinite delivery contract, it supports the agency's mission to maintain uninterrupted access to vital medications. The period of performance for this order is brief, spanning only two days, indicating a prompt fulfillment timeline.
Description
4571085322!ALFUZOSIN HCL ER 10 MG TABLET 1000S